European Archives - Page 538 of 1304 - European Medical Journal

Live Webinar: ECLS with Xenios console | December 12th 7:30 AM - 8:30 AM CET

Join us to get to know Fresenius Medical Care’s ECMO offering – a dedicated technology combining both, heart and lung support in one single platform.

Neurofilament Light Chain Levels Predict Multiple Sclerosis Disability Progression

According to new research, elevation of serum neurofilament light chain, a biomarker of neuroaxonal injury, can predict disability worsening in multiple sclerosis within 1–2 years.

Does Herpes Simplex Virus 1 Increase Risk of Alzheimer’s Disease?

New evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease, according to a systematic review of published studies.

Dr Peter Ahnesorg on why leaders must never stop learning

Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.

Hematology: where's it been and where's it going?

Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.

Meet GOLD’s latest catalyst – Roche’s Dr Peter Ahnesorg

Tune in for a sneak peek of GOLD’s latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.

A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…

EMJ Neurology 11 [Supplement 3] 2023

There is a lot of excitement in the field of amyotrophic lateral sclerosis. Scientific progress has resulted in an ever-growing pipeline…

Therapies to Improve Multiple Myeloma Prognosis Following Relapse

Salvage therapies have been identified in a new US study that could help patients with multiple myeloma, who have tried chimeric antigen receptor T-cell therapy that has been unsuccessful.

Reduced Blood Clot Risk with Post-hormonal Contraceptives

A recent study, revealing that the heightened risk of blood clots associated with hormonal contraceptives significantly diminishes after discontinuation, provides precise guidance on optimal contraceptive cessation timing.